scieee Science in your language
[en] (orig)

Trait- and state-dependent cortical inhibitory deficits in bipolar disorder

Abstract

Objectives Euthymic patients with bipolar disorder (BD) have deficits in cortical inhibition. However, whether cortical inhibitory deficits are trait- or state-dependent impairments is not yet known and their relationship with psychiatric symptoms is not yet understood. In the present study, we examined trait- and state-dependent cortical inhibitory deficits and evaluated the potential clinical significance of these deficits. Methods Nineteen patients with bipolar I disorder were evaluated using the paired-pulse transcranial stimulation protocol, which assessed cortical inhibition during an acute manic episode. Cortical inhibition measures were compared with those obtained in 28 demographically matched healthy controls. A follow-up assessment was performed in 15 of these patients three months later, when there was remission from their mood and psychotic symptoms. The association between cortical inhibitory measures and severity of psychiatric symptoms was also studied. Results During mania, patients showed decreased short-interval intracortical and transcallosal inhibition, as well as a normal cortical silent period and long-interval cortical inhibition. These findings were the same during euthymia. Symptoms associated with motor hyperactivity were correlated negatively with the degree of cortical inhibition. These correlations were not significant when a Bonferroni correction was applied. Conclusions The present longitudinal study showed cortical inhibitory deficits in patients with BD, and supports the hypothesis that cortical inhibitory deficits in BD are trait dependent. Further research is necessary to confirm the clinical significance of these deficits.

Read accessible full text

Trait- and state-dependent cortical inhibitory deficits in bipolar disorder

Author: Ruiz Veguilla, Miguel; Martín Rodríguez, Juan Francisco; Palomar, Francisco J.; Porcacchia, Paolo; Álvarez de Toledo, Paloma; Perona Garcelán, Salvador Félix; Rodríguez Testal, Juan Francisco; Huertas-Fernández, Ismael; Mir Rivera, Pablo
Publisher: Wiley
Year: 2016
DOI: 10.1111/bdi.12382
Source: https://idus.us.es/bitstreams/5caeab9f-44ff-41c6-9d80-bbcfe3f05372/download
Depósi o de In es igación de la Uni e sidad de Se illa
h ps://idus.us.es/
This is he pee e iewed e sion o he ollowing a icle: Ruiz-Veguilla, M., Ma ín-
Rod íguez, J. F., Paloma , F. J., Po cacchia, P., Ál a ez de Toledo, P., Pe ona-Ga celán, S.,
Rod íguez-Tes al, J. F., Hue as-Fe nández, I., & Mi , P. (2016). T ai - and s a e-
dependen co ical inhibi o y de ici s in bipola diso de . Bipola Diso de s, 18(3), 261–
271, which has been published in inal o m a h ps://doi.o g/10.1111/bdi.12382 . This
a icle may be used o non-comme cial pu poses in acco dance wi h Wiley Te ms and
Condi ions o Use o Sel -A chi ed Ve sions. This a icle may no be enhanced, en iched
o o he wise ans o med in o a de i a i e wo k, wi hou exp ess pe mission om Wiley
o by s a u o y igh s unde applicable legisla ion. Copy igh no ices mus no be
emo ed, obscu ed o modi ied. The a icle mus be linked o Wiley’s e sion o eco d
on Wiley Online Lib a y and any embedding, aming o o he wise making a ailable he
a icle o pages he eo by hi d pa ies om pla o ms, se ices and websi es o he han
Wiley Online Lib a y mus be p ohibi ed.
O iginal A icle
T ai - and s a e-dependen co ical inhibi o y
de ici s in bipola diso de
Ruiz-Veguilla M, Ma 
ın-Rod 
ıguez JF, Paloma FJ, Po cacchia P,

Al a ez de Toledo P, Pe ona-Ga cel
an S, Rod 
ıguez-Tes al JF,
Hue as-Fe n
andez I, Mi P. T ai - and s a e-dependen co ical
inhibi o y de ici s in bipola diso de .
Bipola Diso d 2016: 00: 000–000. ©2016 John Wiley & Sons A/S.
Published by John Wiley & Sons L d.
Objec i es: Eu hymic pa ien s wi h bipola diso de (BD) ha e de ici s in
co ical inhibi ion. Howe e , whe he co ical inhibi o y de ici s a e
ai - o s a e-dependen impai men s is no ye known and hei
ela ionship wi h psychia ic symp oms is no ye unde s ood. In he
p esen s udy, we examined ai - and s a e-dependen co ical inhibi o y
de ici s and e alua ed he po en ial clinical signi icance o hese de ici s.
Me hods: Nine een pa ien s wi h bipola I diso de we e e alua ed using
he pai ed-pulse ansc anial s imula ion p o ocol, which assessed
co ical inhibi ion du ing an acu e manic episode. Co ical inhibi ion
measu es we e compa ed wi h hose ob ained in 28 demog aphically
ma ched heal hy con ols. A ollow-up assessmen was pe o med in 15
o hese pa ien s h ee mon hs la e , when he e was emission om hei
mood and psycho ic symp oms. The associa ion be ween co ical
inhibi o y measu es and se e i y o psychia ic symp oms was also
s udied.
Resul s: Du ing mania, pa ien s showed dec eased sho -in e al
in aco ical and anscallosal inhibi ion, as well as a no mal co ical
silen pe iod and long-in e al co ical inhibi ion. These indings we e
he same du ing eu hymia. Symp oms associa ed wi h mo o
hype ac i i y we e co ela ed nega i ely wi h he deg ee o co ical
inhibi ion. These co ela ions we e no signi ican when a Bon e oni
co ec ion was applied.
Conclusions: The p esen longi udinal s udy showed co ical inhibi o y
de ici s in pa ien s wi h BD, and suppo s he hypo hesis ha co ical
inhibi o y de ici s in BD a e ai dependen . Fu he esea ch is
necessa y o con i m he clinical signi icance o hese de ici s.
Miguel Ruiz-Veguilla
a,†
,Juan
F ancisco Ma 
ın-Rod 
ıguez
b, †
,
F ancisco J Paloma
b
,Paolo
Po cacchia
b
,Paloma 
Al a ez de
Toledo
b
,Sal ado Pe ona-
Ga cel
an
a
,Juan F ancisco
Rod 
ıguez-Tes al
a,c
,Ismael
Hue as-Fe n
andez
b
and Pablo Mi
b,d
1
a
G upo Neu odesa ollo y Psicosis, Ins i u o de
Biomedicina de Se illa (IBIS), Hospi al
Uni e si a io Vi gen del Rocio/CSIC/Uni e sidad
de Se illa/UGC Salud Men al HVR,
b
Unidad de
T as o nos del Mo imien o, Se icio de
Neu olog
ıa y Neu o isiolog
ıa Cl
ınica, Ins i u o de
Biomedicina de Se illa, Hospi al Uni e si a io
Vi gen del Roc
ıo/CSIC/Uni e sidad de Se illa,
c
Depa amen o de Pe sonalidad, E aluaci
on y
T a amien os Psicol
ogicos, Facul ad de
Psicolog
ıa, Uni e sidad de Se illa, Se ille,
d
en o de In es igaci
on Biom
edica en Red sob e
En e medades Neu odegene a i as
(CIBERNED), Spain
2
doi: 10.1111/bdi.12382
Key wo ds: co ical inhibi ion – GABA
ecep o s – longi udinal s udy – mo o co ex –
sho -in e al in aco ical inhibi ion –
anscallosal inhibi ion
Recei ed 30 June 2015, e ised and accep ed
o publica ion 8 Feb ua y 2016
Co esponding au ho :
Pablo Mi , M.D., Ph.D.
Unidad de T as o nos del Mo imien o
Se icio de Neu olog
ıa y Neu o isiolog
ıa Cl
ınica
Hospi al Uni e si a io Vi gen del Roc
ıo
A da. Manuel Siu o s/n
Se illa 41013
Spain
Fax: +34-955923101
E-mail: [email p o ec ed]
†
These au ho s con ibu ed equally o his wo k.
Bipola diso de (BD) is a p e alen neu opsychi-
a ic diso de cha ac e ized by pe iods o ele a ed
mood (mania o hypomania) and dep ession. BD
is associa ed wi h signi ican impai men in bo h
he physical and men al quali y o li e, e en du ing
eu hymic pe iods (1). One o he main symp oms
o his diso de is an impai men in he inhibi ion
o inapp op ia e ac ions 3and hough s, esul ing in
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
1
Bipola Diso de s 2016 ©2016 John Wiley & Sons A/S
Published by John Wiley & Sons L d.
BIPOLAR DISORDERS
B D I 12382
Dispa ch: 8.3.16 CE: Sa a anan
Jou nal Code Manusc ip No.
No. o pages: 11 PE: Thanga aj
o e amilia i y, impulsi i y, disinhibi ion, and de i-
ci s in o e bea ing esponse supp ession (2). These
beha io s a e pa icula ly d ama ic du ing mania.
Howe e , indi iduals wi h BD also display inhibi-
o y de ici s in dep ession and eu hymia (3–5), sug-
ges ing ha inhibi o y de ici s could be pa o he
co e symp oms o BD. I has been sugges ed ha
inhibi o y de ici s in BD a e ela ed o impai men
in co ical inhibi ion in which co ical c-aminobu-
y ic acid (GABA) inhibi o y in e neu ons play a
c ucial ole in inhibi ing he ac i i y o o he co i-
cal neu ons (6). In his ega d, expe imen al e i-
dence suppo s an in ol emen o he GABA
sys em in he pa hophysiology o BD. Mo eo e ,
gene ic associa ion s udies ha e ound dis inc
polymo phisms o GABA ecep o genes associ-
a ed wi h BD (7, 8), and abno mali ies in he
exp ession o mul iple GABA- ela ed p o eins
ha e been epo ed in pos mo em s udies in
pa ien s wi h BD (9, 10).
In o ma ion abou he unc ionali y o he co i-
cal GABAe gic sys em can be indi ec ly ob ained
using ansc anial magne ic s imula ion (TMS). By
using single- and pai ed-pulse TMS, i is possible
o assess he ac i i y o he GABAA and GABAB
ecep o s in he mo o co ex, as well as he physi-
ological in e ac ions be ween exci a o y and inhi-
bi o y ci cui s in human subjec s (11, 12). The
sho -in e al co ical inhibi ion (SICI) pa adigm
assesses he inhibi ion o he mo o ac i i y
induced by a condi ioned magne ic s imulus ha is
p esen ed sho ly (2–5 msec) be o e ano he s imu-
lus ha is able o p o oke a measu able mo o
e oked po en ial (MEP). This ype o inhibi ion
has been ela ed o he ac i i y o GABAA ecep-
o s (13). Addi ional measu es o co ical inhibi-
ion include he co ical silen pe iod (CSP) and
long-in e al in aco ical inhibi ion (LICI), which
a e bo h measu es o long-las ing in aco ical
inhibi ion and hough o be dependen on
GABAB ecep o ac i i y (14, 15). Ano he co i-
cal inhibi o y phenomenon, anscallosal inhibi-
ion (TCI), can be assessed wi h TMS using ei he
pai ed-pulse pa adigms o ia he ipsila e al silen
pe iod. Al hough in e hemisphe ic co icoco ical
inhibi o y mechanisms a e no ully unde s ood,
hey equi e he in ac in eg i y o callosal ibe
bundles, and p esumably also equi e a p ese ed
in aco ical GABAe gic inhibi o y in e neu on
sys em (16, 17).
Few TMS pape s ha e s udied co ical inhibi-
o y mechanisms in BD. Le inson e al. (18)
demons a ed se e al co ical inhibi o y de ici s
consis ing o dec eased SICI, TCI, and CSP,
which sugges s impai ed co ical GABAe gic
ecep o ac i i y in pa ien s wi h BD. By con as ,
LICI seems o be main ained in pa ien s wi h BD,
as obse ed in a combined TMS–elec oen-
cephalog aphy s udy (19). These p e ious s udies
ha e in es iga ed he ai and s a e ma ke s o
BD by compa ing co ical inhibi ion in eu hymic
pa ien s wi h BD wi h con ol subjec s in a c oss-
sec ional case-con ol design. The e is he e o e
he possibili y o in e subjec di e ences a ec ing
he a iabili y in co ical exci abili y, and i is di i-
cul o in es iga e he unde lying co ical inhibi-
o y de ici s o ai and s a e abno mali ies and
mood swi ching using such a design. Subs ance
abuse is a majo como bidi y in pa ien s wi h BD,
which may ha e p o ound clinical implica ions
(20, 21). Subs ances such as cannabis, cocaine, o
nico ine ha e been shown o al e co ical inhibi-
ion bo h in he non-psychia ic (22) and psychi-
a ic popula ion (23). Likewise, co ical
exci abili y and inhibi ion is also modula ed by
commonly used d ugs o ea BD, including
mood s abilize s, benzodiazepines, and an ipsy-
cho ic agen s. The e o e, como bid subs ance
abuse o cu en pha macological ea men
should be aken in o accoun when assessing co i-
cal exci abili y and inhibi ion in BD. To add ess
hese issues, we conduc ed a longi udinal s udy
wi h a TMS design o assess pa ien s du ing he
acu e manic phase (BD manic) and emission
om his acu e phase. We also assessed he associ-
a ion be ween co ical inhibi o y measu es, se e -
i y o psychia ic symp oms, and li e ime and
cu en d ug use.
Me hods
Pa icipan s
A o al o 19 igh -handed pa ien s wi h BD pa ic-
ipa ed in he s udy ( en pa ien s had i s -episode
BD; 12 males; mean age: 35.5 yea s; mean age a
onse : 30.4 yea s). Pa ien s we e ec ui ed o e a
wo-yea a pe iod om he Inpa ien Psychia ic
Uni o he Hospi al Uni e si a io Vi gen del
Roc
ıo Men al Heal h Depa men . Eligible
pa ien s me he diagnos ic c i e ia o bipola I
diso de , acco ding o DSM-IV classi ica ion s an-
da ds. The pa icipan s we e equi ed o ha e a
Young Mania Ra ing Scale (YMRS) (24) sco e
≥18. We excluded pa ien s: (i) <18 o >65 yea s o
age; (ii) wi h a his o y o b ain auma o neu o-
logical disease; and (iii) i hey had unde gone elec-
ocon ulsi e he apy in he p e ious 12 mon hs.
All pa ien s displayed acu e mania wi h a YMRS
>21 and none displayed majo dep essi e symp-
oms. In i s -episode BD, diagnosis was con i med
a e one yea o ollow-up.
2
Ruiz-Veguilla e al.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
A heal hy con ol g oup consis ing o 28 heal hy
subjec s was ec ui ed by ad e isemen , in addi-
ion o wo d-o -mou h eques s om s a in he
esea ch uni . Pa ien and con ol g oups we e
ma ched ia ec ui men by age, gende , and
social/occupa ional class. The heal hy con ols
exhibi ed no pas o p esen psychia ic o neu o-
logical diso de s and had no posi i e amily his o y
o psychia ic diso de s. O he exclusion c i e ia
o his g oup we e li e ime subs ance dependence,
subs ance abuse du ing he p e ious mon h, can-
nabis abuse du ing he p e ious mon h, in ellec ual
disabili y, demen ia, and neu ological illnesses.
Six een pa ien s ag eed o pa icipa e in he ol-
low-up assessmen and h ee wi hd ew du ing he
cou se o he s udy ( wo o hem mo ed o o he
ci ies a e discha ge and one no longe wished o
pa icipa e u he in he s udy). All pa ien s we e
eu hymic a he ollow-up assessmen , as de ined
by a YMRS sco e <7 and a Hamil on Dep ession
Ra ing Scale (HDRS) (25) sco e <10. Du ing he
one-yea ollow-up, one pa ien displayed symp-
oms consis en wi h schizoa ec i e diso de , so
was excluded om he analysis.
S udy design
This was a longi udinal and na u alis ic s udy ha
consis ed o comp ehensi e psychopa hological and
TMS assessmen s a wo poin s: baseline and a
h ee-mon h ollow-up. Baseline assessmen s we e
comple ed in he second week o hospi al admission.
Th ee mon hs a e hospi al discha ge, pa ien s we e
in i ed o pa icipa e in a second assessmen .
Heal hy subjec s unde wen a unique TMS assess-
men . The s udy p o ocol was app o ed by he local
e hics commi ee, and all p ocedu es ollowed we e
in acco dance wi h ins i u ional guidelines. W i en
in o med consen was ob ained om all subjec s.
Following sc eening o exclusion c i e ia, all
pa icipan s unde wen a de ailed examina ion by
expe ienced psychia is s o assess cu en mood
s a e. BD was diagnosed using he S uc u ed Clin-
ical In e iew o DSM-IV Diso de s, esea che
e sion wi h psycho ic sc een (26). Mood was also
a ed using he YMRS and he HDRS. Psycho ic
symp oms we e assessed using he Posi i e and
Nega i e Symp oms Scale (PANSS) (27). T ained
in e iewe s adminis e ed he PANSS as pa o a
s uc u ed clinical in e iew and sco ed i ems on a
scale om 1 (asymp oma ic) o 7 (ex emely symp-
oma ic). I ems o he PANSS we e g ouped using
Wallwo k e al.’s i e- ac o (posi i e, nega i e,
diso ganized/conc e e, exci ed, and dep essed)
model (28). Highe sco es in hese ac o s imply a
highe se e i y o psycho ic symp oms.
TMS assessmen s we e pe o med be ween 3:00
p.m. and 5:00 p.m. Doses o he a ypical an ipsy-
cho ic agen s we e ans o med o chlo p omazine
equi alen s (29). Du ing bo h assessmen s, benzo-
diazepines we e wi hd awn a leas 15 hou s p io
o he TMS s udy. Blood samples we e d awn o
de e mina ion o se um li hium and alp oic acid
le els du ing clinical examina ions. E ec i e
se um li hium le els we e de ined as concen a-
ions be ween 0.6 mEq/L and 1.0 mEq/L, while
e ec i e alp oic acid le els we e de ined as
be ween 50 mg/L and 100 mg/L. Pa e ns o can-
nabis and cocaine abuse we e assessed using he
L-sec ion o he Composi e In e na ional Diag-
nos ic In e iew (CIDI) (30). We in e iewed sub-
jec s on li e ime d ug use his o y and pa e ns o
d ug use du ing he p e ious 12 mon hs. U ine
oxicology sc eening (TOX/See; Bio-Rad 4, USA)
was pe o med in all pa ien s o con i m o ule
ou cu en exposu e o ha m ul d ugs. Nico ine
dependence was assessed in bo h g oups using he
Fage s €
om es o nico ine dependence (31). A
sco e ≥4 by combining i ems 1 and 4 o his es
was used o iden i y subjec s wi h high nico ine
dependence (32).
Elec omyog aphy (EMG) eco dings
Subjec s we e sea ed in a com o able chai and
su ace EMG eco dings we e aken a he i s
do sal in e osseous (FDI) muscles on he side
con ala e al o he s imula ed co ex wi h
Ag–AgCl su ace elec odes using a belly– endon
mon age. EMG signals we e ampli ied (1,0009)
and band-pass il e ed (bandwid h 20 Hz o
2 kHz) using a Digi ime D360 ampli ie (Dig-
i ime 5, UK), acqui ed a a sampling a e o
5 kHz h ough a CED 1401 labo a o y in e ace
(Camb idge Elec onic Design, Camb idge, UK)
and s o ed on a compu e . The EMG aces we e
analyzed using cus omized SIGNAL so wa e
e sion 4 6.
S imula ion p o ocols
Single- and pai ed-pulse TMS o he p ima y
mo o co ex we e applied using Mags im 200
magne ic s imula o s (Mags im Company Limi ed,
Whi land, UK). The s imula o s we e igge ed
h ough he SIGNAL so wa e and CED 1401
boa d. Pa ien s and heal hy subjec s we e es ed on
he le hemisphe e in a TMS session ha included
SICI, in aco ical acili a ion (ICF), LICI, and
CSP. Fo hese s udies, he magne ic s imula o s
we e connec ed o a s anda d igu e-o -eigh coil
wi h an ex e nal diame e o 70 mm (peak mag-
3
Mo o co ical disinhibi ion in BD
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
ne ic ield 2.2T). The coil was held angen ially o
he skull wi h he handle poin ing backwa ds and
la e ally a an angle o ~45 deg ees o he sagi al
plane in o de o gene a e a pos e io –an e io cu -
en in he b ain. A BiS im module (Mags im
Company Limi ed) was used o in e connec s imu-
la o s when pai ed-pulse TMS p o ocols we e pe -
o med. SICI and ICF we e assessed o e he
con ala e al FDI muscle in a simila way o a p e-
iously desc ibed pai ed-pulse pa adigm (33),
whe eby a sub h eshold s imulus is used o condi-
ion he mo o ou pu o a sup a h eshold s imu-
lus, depending on he ime in e al be ween hem.
The in ensi y o he condi ioning s imulus (CS)
was 80% o he ac i e mo o h eshold (AMT),
de ined as he minimum in ensi y ha elici ed a
ep oducible MEP o a leas 200 lV in he oni-
cally con ac ing FDI muscle in a leas i e ou o
en consecu i e ials, while subjec s we e con ac -
ing a app oxima ely 20% o hei maximum ol-
un a y con ac ion. A cons an le el o muscle
con ac ion was achie ed by he use o isual eed-
back. The in ensi y o he es s imulus (TEST) was
adjus ed o elici an MEP o app oxima ely 1 mV.
SICI and ICF we e assessed in he same expe i-
men al block. SICI was assessed a es a in e -
s imulus in e als (ISIs) be ween he CS and a
TEST o 2 msec and 3 msec, and ICF a ISIs o
10 msec and 12 msec. The p esen a ion o TEST
and CS we e andomly in e mingled
7wi hin he
SICI–ICF expe imen al block. Fo assessmen o
LICI, he in ensi y o he CS was 120% o he es -
ing mo o h eshold (RMT) o he con ala e al
FDI muscle. RMT was de ined as he minimum
in ensi y ha e oked a peak- o-peak MEP o
50 lV in a leas i e ou o en consecu i e ials in
he elaxed eco ded muscle (34). LICI was
assessed a es a ISIs o 100 msec, 150 msec, and
250 msec. Ten MEPs we e collec ed o each ISI
and o he TEST. The p esen a ion o TEST and
CS s imuli we e andomly
8in e mingled wi hin he
LICI expe imen al blocks. Fo assessmen o CSP,
15 single TMS pulses we e applied a an in ensi y
o 120% RMT, while pa ien s p o ided a cons an
con ac ion o he FDI muscle a 20% o hei
maximum olun a y con ac ion, assis ed by isual
eedback. TCI was demons a ed using he dual-
pulse pa adigm desc ibed by Fe be e al. (17).
B ie ly, wo igu e-o -eigh coils (wi h an ou e
diame e o each hal -wing o 40 mm) we e used
wi h a TEST applied o he le mo o co ex and a
CS applied o he igh mo o co ex. Wi h hese
coils, RMT was again ob ained a bo h hemi-
sphe es
9. The TEST s imulus was se a an in ensi y
ha , when gi en alone, would e oke an EMG
esponse o 1 mV peak- o-peak ampli ude. The CS
was applied a 120% o he RMT. TCI was es ed
a ou condi ioning es in e als (7, 10, 45, and
75 msec), gi en in a andom o de , wi h a o al o
en sweeps o 10each condi ion.
S a is ical analysis
S uden ’s - es s o independen measu es and
Fishe ’s exac es we e used o in es iga e di e -
ences be ween pa ien s and heal hy con ols on
demog aphic a iables (i.e., age, gende , smoking
a iables, and d ug abuse his o y a iables). Fish-
e ’s exac es and pai ed-sample - es s we e used
o assess changes in clinical a iables a he ol-
low-up assessmen . The independen and
epea ed-measu es - es s we e used o de e mine
di e ences in mo o h esholds and CSP. Two sep-
a a e wo-way ixed-e ec s analyses o a iance
(ANOVAs) we e conduc ed o he e alua ion o
pai ed-pulse TMS p o ocols. To de ec co ical
inhibi o y de ici s du ing mania, TMS da a col-
lec ed om pa ien s in his episode we e compa ed
wi h hose ob ained om heal hy subjec s. This
analysis was ca ied ou wi h ISI as wi hin-subjec
ac o and G oup (heal hy e sus manic g oups) as
be ween-subjec ac o . Po en ial con ounde s (use
o cannabis, cocaine, obacco, and benzodi-
azepines) we e included in a seconda y model
analysis i a signi ican g oup di e ence was seen
in he p ima y analysis. To assess he longi udinal
e ec s o mood episodes on co ical inhibi ion, a
epea ed-measu e ANOVA wi h wo wi hin-sub-
jec ac o s, episode (manic and eu hymia) and
ISI, was used. Mauchly’s es assessed sphe ici y
and he G eenhouse–Geisse co ec ion was used
o non-sphe ical da a. Signi ican main e ec s
and in e ac ions in ANOVA we e ollowed by
pos -hoc independen o pai ed - es s wi h Bon-
e oni co ec ion. The ela ionship be ween clini-
cal symp om se e i y and TMS measu es in he
BD g oup was examined using he Pea son p o-
duc -momen co ela ion coe icien . A Bon e oni
co ec ion was applied o he co ela ion analysis,
se ing he signi icance cu -o a p <0.001. A
powe analysis using he Gpowe compu e p o-
g am 11(35) indica ed ha , gi en ou sample size, we
would expec o de ec mode a e e ec sizes
( =0.25), powe ed, 86%, a a signi ican le el o
p<0.05.
Resul s
Demog aphic da a and a his o y o subs ance use
bo h in pa ien s wi h BD and heal hy subjec s a e
displayed in Table 1. Mos pa ien s wi h BD we e
cu en ciga e e smoke s, al hough nico ine depen-
4
Ruiz-Veguilla e al.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56

dence measu es did no di e s a is ically be ween
pa ien s and con ols. Ten pa ien s epo ed a his-
o y o cannabis use, while daily cannabis use was
asce ained in six o hem. A posi i e u ine es o
cannabis was ound in nine o hem. In all o hese
cases, ime since he las cannabis exposu e
exceeded one week. Fou pa ien s epo ed a his o y
o cocaine use. All o hem, excep one, epo ed no
cocaine use in he p e ious yea . A posi i e u ine
es o cocaine was p esen in one pa ien , who
epo ed hei las cocaine consump ion o ha e
aken place in he p e ious mon h.
Table 2 shows changes in clinical and pha ma-
cological a iables in pa ien s du ing mania and
eu hymia. O e all, a signi ican imp o emen in
manic, posi i e, and gene al psycho ic symp oms
was obse ed (all p <0.001) in he ollow-up
assessmen . Ten ou o he 15 pa ien s sco ed
ze o in he YMRS. We also de ec ed a signi ican
inc ease in he se e i y o dep essi e symp oms in
he ollow-up assessmen . Fu he mo e, a signi i-
can dec ease in cannabis consump ion (i.e.,
es s posi i e o cannabis) was obse ed du ing
ollow-up.
Mo o h esholds
The da a on mo o h esholds a e shown in
Table 3. No signi ican di e ences could be
demons a ed in RMT in pa ien s wi h BD
(p =0.75 o pa ien s in he manic phase and
p=0.12 o eu hymic pa ien s). The e we e no s a-
is ically signi ican di e ences be ween heal hy
con ols and pa ien s wi h BD in he o he mo o
h esholds ob ained o igh FDI muscle (all
p>0.37). Likewise, no signi ican di e ences in
he mo o h esholds we e ound be ween pa ien s
du ing he manic episode and du ing eu hymia (all
p>0.86).
Co ical inhibi ion du ing he manic episode
SICI and ICF. A signi ican main e ec o
ISI (F
3,132
=49.6, p <0.001) and ISI 9g oup
in e ac ion (F
3,44
=6.6, p <0.001) we e ob ained.
Table 1. Pa icipan demog aphics and subs ance use da a
Bipola
diso de
(n =19)
Heal hy
con ols
(n =28) p- alue
Gende , male/ emale 12/7 18/10 0.937
Age, yea s,
mean SD
35.5 11.4 33.1 7.0 0.434
Cu en ciga e e
smoke , n
13 5 <0.001
FTND sco e, mean SD 3.19 0.9 2.92 0.4 0.168
High nico ine
dependence, n
6 2 0.065
Cannabis use his o y, n 10 0 <0.001
Posi i e u ine es , n 9 0 N/A
Daily smoke , n 6 –N/A
Weekly smoke , n 4 –
Time since las join ,
days, mean SD
17.3 27.6 –N/A
Age a onse , yea s,
mean SD
19.4 4.1 –N/A
Du a ion o use, yea s,
mean SD
9.5 5.1 –N/A
Cocaine use his o y, n 4 0 0.022
Posi i e u ine es , n 1 0 N/A
Daily cocaine use , n 2 –N/A
3–4 days a week, n 1 –N/A
1–2 days a week, n 1 –N/A
Age a onse , yea s,
mean SD
24.2 6.7 –N/A
Du a ion o use, yea s,
mean SD
7.4 5.5 –N/A
O he d ugs, n 0 0 N/A
FTND =Fage s €
om es o nico ine dependence; N/A =no
applicable; SD =s anda d de ia ion.
Table 2. Clinical cha ac e is ics o pa ien s who comple ed he ollow-
up s udy
Manic
episode
(n =15)
Eu hymic
episode
(n =15) p- alue
a
Mood s abilize , n
Li hium 7 3 0.428
Sodium alp oa e 8 8
Se um li hium le els,
mmol/L, mean (SD)
0.61 (0.08) 0.72 (0.21) 0.336
Se um alp oa e
le els, mg/L,
mean (SD)
59.6 (23.4) 49.2 (11.2) 0.346
An ipsycho ic
agen s, n
15 13 0.483
An ipsycho ic
agen doses,
chlo p omazine
equi alen s, mean
(SD)
649.8 (339.3) 595.8 (380.1) 0.392
Benzodiazepines, n 6 3 0.427
Cu en ciga e e
smoke , n
9 9 1.000
Cannabis use, n 8 2 0.020
YMRS sco e,
mean (SD)
35.1 (7.1) 1.5 (2.8) <0.001
HDRS sco e,
mean (SD)
1.2 (1.6) 2.9 (2.5) 0.039
PANSS sco e,
mean (SD)
Posi i e ac o 3 (1.1) 1.1 (0.3) <0.001
Nega i e ac o 1.3 (0.9) 1.4 (0.7) 0.309
Diso ganized/
Conc e e ac o
3.4 (0.8) 1.3 (0.5) <0.001
Exci ed ac o 4.1 (0.9) 1.2 (0.3) <0.001
Dep essed ac o 1.6 (0.1) 1.6 (0.7) 0.770
HDRS =Hamil on Dep ession Ra ing Scale; PANSS =Posi i e
and Nega i e Synd ome Scale; SD =s anda d de ia ion;
YMRS =Young Mania Ra ing Scale.
a
Fishe ’s exac es o pai ed-samples - es s.
5
Mo o co ical disinhibi ion in BD
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
Pos -hoc analysis e ealed ha pa ien s wi h BD
du ing mania showed less SICI a ISIs 2 msec
(p <0.001) and 3 msec (p <0.05), while no di e -
ences we e ound in ICF (p >0.2) (Fig. 1A). A e -
aged ac oss bo h inhibi o y ISIs (2 msec and
3 msec), pa ien s du ing mania demons a ed
33.2% less inhibi ion compa ed wi h heal hy sub-
jec s (
44
=3.3, p =0.002). The e we e no di e -
ences be ween g oups when ICF measu es we e
pooled (p =0.203). Di e ences in SICI measu es
emained s a is ically signi ican a e con olling
o cu en obacco smoking (es ima ed ma ginal
means o SICI in he BD g oup =0.78, heal hy
g oup =0.36, p =0.01). We also assessed he e ec
o cu en o pas cannabis use on SICI measu es
in pa ien s wi h BD. In he mul i a ia e model,
he e was a signi ican e ec o ISI (p <0.001),
while nei he he ISI 9cu en cannabis use
(p =0.571) no cu en cannabis use main ac o
(p =0.947) eached signi ican le els. Simila
esul s we e ob ained a e including he a iables
equency o cu en cannabis smoking (in e ac ion
wi h ISI, p =0.287; main e ec , p =0.655), ime
since las join (p =0.166), age a cannabis use onse
(p =0.639), o du a ion o cannabis use (p =0.734)
on SICI 12. His o y o cocaine use did no show a sig-
ni ican main e ec (p =0.482) o in e ac ion wi h
ISI (p =0.117). Pa ien s on benzodiazepine ea -
men showed enhanced SICI a bo h 2 msec and
3 msec (bo h p <0.05, as compa ed wi h pa ien s
wi hou benzodiazepines).
Long-in e al co ical 14inhibi ion. A main e ec o
ISI (F
3,135
=17.28, p <0.001) was ound, indica -
ing a signi ican MEP educ ion when a condi-
ioned s imulus was applied bo h o con ols and
pa ien s (p <0.001). Howe e , no signi ican main
e ec o g oup (F
1,47
=0.022, p =0.883) o he
in e ac ion ISI 9g oup (F
3,141
=0.449, p =0.718)
was ound o his p o ocol.
CSP. The du a ion o CSP did no di e be ween
pa ien s wi h mania and heal hy con ols (mean
CSP du a ion manic pa ien s =110.3 msec; con-
ols =116.09 msec;
45
=0.708, p =0.483).
TCI. One pa ien could no comple e his p o o-
col. Signi ican main e ec s o ISI (F
3,129
=22.1,
p<0.001) and g oup (F
1,43
=7.8, p =0.008) we e
ob ained, while he g oup 9ISI in e ac ion was
no signi ican (F
4,43
=1.05, p =0.359) (Fig. 1B).
Planned - es s showed dec eased TCI in manic
pa ien s a ISIs 7 msec (p =0.021) and 10 msec
(p =0.018). A e a e aging ac oss all sho -in e -
al in e hemisphe ic inhibi o y ISIs (i.e., 7 msec
and 10 msec), pa ien s wi h BD displayed less inhi-
bi ion han heal hy con ols (17.5%, p =0.033).
An in e ac ion be ween cu en obacco smoking
and g oup was also de ec ed (F
1,44
=4.33,
p=0.044). Pos -hoc analysis e ealed ha smoke
Table 3. TMS in ensi y (% o maximum s imula o ou pu ) used in he
TMS assessmen s o pa ien s wi h bipola diso de and heal hy sub-
jec s
Heal hy
con ols
Manic
episode
Eu hymic
episode
Ac i e mo o h eshold
( igh FDI muscle)
31.8 1.3 32.1 1.7 32.2 1.8
Res ing mo o h eshold
( igh FDI muscle)
40.8 1.3 42.5 2.1 41.2 2.5
In ensi y MEP 1 mV
( igh FDI muscle)
49.4 1.9 51.4 2.5 51.2 2.6
Res ing mo o h eshold
( igh FDI muscle)
a
43.0 1.8 42.7 2.2 44.9 2.3
Res ing mo o h eshold
(le FDI muscle)
a
41.7 1.4 43.9 3.2 43.3 2.6
Values epo ed as mean s anda d de ia ion. FDI = i s do -
sal in e osseous; MEP =mo o e oked po en ial; TMS = an-
sc anial magne ic s imula ion.
a
Th esholds ob ained using 40-mm coils di ec ly connec ed o
he s imula o s.
AB
TEST
2 msec
3 msec
10 msec
12 msec
0.0
0.5
1.0
1.5
MEP ampli ude
No malized by TEST ampli ude
*** *
TEST
7 msec
10 msec
45 msec
75 msec
0.0
0.5
1.0
MEP ampli ude
No malized by TEST ampli ude
*
*
Fig. 1. (A) Sho -in e al in aco ical inhibi ion and in aco ical acili a ion in pa ien s wi h bipola diso de and heal hy subjec s.
(B) T anscallosal inhibi ion in pa ien s wi h bipola diso de and heal hy subjec s as a unc ion o he in e s imulus in e al be ween
he condi ioning and he es s imuli. Mean s anda d e o om pa ien s du ing he manic episode (black ba s, n =19) and
heal hy con ols (g ay ba s, n =28). Values <1 indica e inhibi ion. *p<0.05, ***p13
<0.001: independen - es s wi h Bon e oni co -
ec ion o mul iple compa isons. MEP =mo o e oked po en ial.
6
Ruiz-Veguilla e al.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
pa ien s wi h BD displayed TCI le els ha we e
compa able wi h hose ob ained in he heal hy
g oup (p =0.441), while TCI le els in non-smoke
pa ien s wi h BD we e signi ican ly educed
(p =0.018, as compa ed wi h heal hy subjec s).
Cu en obacco smoking did no a ec TCI le els
in heal hy subjec s (p =0.690). A cu en o pas
his o y o cannabis use did no show he main
e ec (p =0.221) o in e ac ion wi h ISI
(p =0.368). Likewise, equency o cu en cannabis
smoking did no show an e ec on TCI esul s (in-
e ac ion wi h ISI, p =0.637; main e ec ,
p=0.257). O he a iables ha did no in luence
TCI le els in pa ien s wi h BD included ime since
las join (p =0.993), age a cannabis use onse
(p =0.999), and du a ion o cannabis use
(p =0.837). A his o y o cocaine use did no show
a signi ican main e ec (p =0.419) o in e ac ion
wi h ISI (p =0.611). Nei he he main e ec o
benzodiazepine (p =0.287) no in e ac ion o ben-
zodiazepine wi h TCI ISIs we e signi ican
(p =0.596).
Co ical inhibi ion du ing eu hymia
SICI and ICF. A signi ican main e ec o ISI
(F
3,36
=10.06, p <0.001), bu no episode
(F
1,12
=0.007, p =0.935) o in e ac ion episode 9
ISI (F
3,36
=0.056, p =0.784), was ound in he ol-
low-up s udy, indica ing no di e ences be ween
pa ien s du ing manic and eu hymic phases a any
e alua ed condi ion
15 (Fig. 2A). Cu en obacco
smoking in he model did no s a is ically al e
hese esul s (p =0.575). Cannabis, cocaine, and
benzodiazepine e ec s we e no analyzed a he ol-
low-up assessmen owing o he small numbe o
pa ien s unde hese condi ions.
Long-in e al co ical inhibi ion
17 .No signi ican
main e ec o episode (F
1,13
=0.196, p =0.665)
o in e ac ion episode 9ISI (F
2,26
=1.764,
p=0.191) was ound in he ollow-up s udy.
Silen pe iod. No signi ican di e ences we e
ound be ween pa ien s in manic and eu hymic
phases (
14
=1.009, p =0.331).
TCI. Analysis o di e ences be ween he manic
episode and he ollow-up assessmen e ealed a
signi ican main ac o ISI (F
3,39
=7.94,
p<0.001), whe eas nei he main ac o episode
(F
1,13
=1.132, p =0.307) no he in e ac ion
be ween episode and ISI (F
3,36
=0.623, p =0.604)
we e signi ican (Fig. 2B). A signi ican main e ec
o obacco was also ound in he mul i a ia e anal-
ysis (F
1,13
=4.86, p =0.046). Cu en obacco
smoke s showed an inc eased mean TCI compa ed
wi h non-smoke s.
Rela ionship be ween se e i y o psychia ic symp oms
and measu es o co ical inhibi ion
SICI and TCI le els (a e aged ac oss all inhibi o y
ISIs) co ela ed posi i ely bo h in manic episode
and eu hymia. Pa ien s wi h a high sco e in he
PANSS exci ed ac o du ing he manic episode
displayed less SICI and TCI du ing bo h he manic
episode and eu hymia. PANSS diso ganized ac o
co ela ed posi i ely wi h he posi i e and nega i e
ac o s o he same scale. Mo eo e , he PANSS
dep essed ac o showed a nega i e co ela ion
wi h he HDS 18du ing mania. These co ela ions
did no each signi icance a e he Bon e oni co -
ec ion. The ull co ela ion ma ix is p esen ed in
Supplemen a y Table 1.
We also conduc ed a co ela ion analysis wi h
YMRS i em 2, which assesses inc eased mo o
ac i i y and ene gy. The sco e in his i em co e-
la ed nega i ely wi h he deg ee o co ical inhibi-
ion in bo h manic and eu hymic episodes bu
TEST
2 msec
3 msec
10 msec
12 msec
0.0
0.5
1.0
1.5
A
MEP ampli ude
No malized by TEST ampli ude
Tes
7 msec
10 msec
45 msec
75 msec
0.0
0.5
1.0
B
MEP ampli ude
No malized by TEST ampli ude
Fig. 2. (A) Sho -in e al in aco ical inhibi ion and in aco ical acili a ion in pa ien s wi h bipola diso de du ing he manic epi-
sode (g ay ba s) and eu hymia (whi e ba s 16
). (B) T anscallosal inhibi ion in pa ien s du ing he manic episode and eu hymia. Fi een
pa ien s we e included in his ollow-up s udy. Values <1 indica e inhibi ion. No signi ican di e ence in co ical inhibi ion be ween
manic episode and eu hymia was ound. Pai ed sample - es s wi h Bon e oni co ec ion o mul iple compa ison. MEP =mo o
e oked po en ial.
7
Mo o co ical disinhibi ion in BD
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
hese did no each signi icance a e he Bon e -
oni co ec ion (SICI mania: ho =0.632,
p=0.006; SICI eu hymia: ho =0.562,
p=0.046; TCI mania: ho =0.526, p =0.065;
TCI eu hymia: ho =0.409, p =0.103).
Discussion
We ound ha pa ien s wi h BD du ing mania dis-
play speci ic co ical inhibi o y de ici s –namely,
al e ed SICI and TCI. The deg ee o co ical inhibi-
ion was simila du ing mania and eu hymia, sug-
ges ing ha co ical inhibi o y de ici s cons i u e a
ai ma ke o BD. In an explo a o y co ela ion
analysis, se e al associa ions be ween psychopa ho-
logical symp om se e i y and co ical inhibi o y
measu es we e de ec ed. I should be highligh ed
ha pa ien s who sco ed high on i ems assessing
mo o hype ac i i y and goal-di ec ed beha io
(i.e., PANSS exci ed ac o i ems
19 , YMRS i em 2)
du ing mania displayed highe co ical SICI and
TCI de ici s bo h in manic episodes and eu hymia.
Se e al e o s ha e been made o dis inguish
which cogni i e, emo ional, and mo i a ional
al e a ions o BD a e mood-s a e dependen o
ai ma ke s by examining pa ien s ac oss a ious
mood s a es, including eu hymia (36, 37). How-
e e , ai - and s a e-dependen co ical inhibi o y
de ici s ha e no been ex ensi ely s udied, despi e
he ac ha hese de ici s ha e been linked o
impulsi eness, a co e symp om o BD (21, 38, 39).
Indeed, clinical scales o assess BD usually include
mo o ac i i y i ems. Thus, i may seem easonable
o e alua e ai - and s a e-dependen co ical
exci abili y/inhibi ion as an indica o o he neu-
opa hophysiology unde lying mo o de ici s in
mood diso de s. Ou esul s, which con i m and
u he ex end p e ious obse a ions in eu hymic
pa ien s (18, 19), include se e al new obse a ions
on mania ha p o ide a mo e comple e unde -
s anding o mo o inhibi ion de ici s in BD. In pa -
icula , he longi udinal design used in ou s udy
empowe ed he gene alizabili y o ou da a o he
comple e cou se o BD, no limi ed o a speci ic
ype o episode.
Al e ed co ical inhibi ion has been obse ed in
se e e psycho ic and mood diso de s, in spi e o
he concomi an
20 ele a ed pe iphe al and b ain
GABA le els (40, 41). The e o e, a plausible
hypo hesis o he mechanism in ol ed in co ical
inhibi o y de ici s seen in BD would in ol e al e -
a ions in he GABA ecep o sys em. Pha maco-
logical s udies sugges he in ol emen o GABAA
ecep o s in SICI assessed in he p ima y mo o
co ex. The e o e, and in ag eemen wi h Le inson
e al. (18), de ici s in SICI could e idence an
impai men in as inhibi o y co ical p ocesses
likely o in ol e GABAA ecep o s (42). We also
ound ha benzodiazepines modula ed he SICI
le el in pa ien s wi h BD du ing mania – ha is,
pa ien s aking benzodiazepines du ing he manic
episode displayed simila SICI le els o heal hy
con ols, while pa ien s wi hou his ea men dis-
played signi ican ly educed SICI le els. The e ec
o benzodiazepines on SICI could no be es ed
du ing eu hymia as only h ee pa ien s we e aking
benzodiazepines a ollow-up. The enhancing e ec
o benzodiazepines on SICI is consis en ly epo ed
in he pha maco-TMS li e a u e (43) and could
unde lie he indings in BD epo ed he e. The e-
o e, i is possible ha he SICI educ ion obse ed
in he manic phase could ha e been e en highe
han ha ob ained in he cu en s udy i pa ien s
had no been on benzodiazepine ea men . This
possibili y does no make ou main indings oid
as manic pa ien s s ill show de ici s in SICI, and
his does no change du ing eu hymia.
In addi ion o de ici s ound in SICI, in e hemi-
sphe ic inhibi ion a sho ISIs (7 msec and
10 msec) was also ound o be abno mal bo h in
manic and eu hymic episodes. Al hough he exac
mechanisms media ing TCI emain unde in es i-
ga ion, he e is a en a i e consensus on he
in ol emen o anscallosal glu ama e gic pa h-
ways linking wi h py amidal ac neu ons h ough
GABAe gic in e neu ons (44). In humans, TCI is a
obus phenomenon and occu s o e a wide ange
o ISIs (6–50 msec). Howe e , eme ging e idence
sugges s ha TCI elici ed a sho ISIs is media ed
by di e en mechanisms han ha elici ed a longe
in e als (45). Animal s udies ha e sugges ed ha
he ea ly las ing o m o TCI is media ed by
GABAA ecep o s (46). Ne e heless, da a in
humans a e inconclusi e (47, 48). Ano he po en-
ial ac o ha may unde lie TCI de ici s in BD
ega ds ana omical al e a ions in he co pus callo-
sum, such as he educed callosal wid h docu-
men ed in his popula ion (49, 50).
Subs ance use was no con olled in ou s udy.
The e o e, he e ec o hese a iables on co ical
inhibi o y measu es was analyzed sepa a ely in
mul i a ia e analyses. Consis en wi h o he s ud-
ies, pa ien s wi h BD displayed high a es o cu -
en and li e ime cannabis, cocaine, and obacco
use (20, 51). The analysis o cannabis and cocaine
use showed no e ec o hese subs ances on TMS
measu es in BD du ing mania. We also obse ed a
signi ican dec ease in he numbe o pa ien s wi h-
ou cannabis and cocaine use du ing ollow-up
(e.g., eigh pa ien s epo ed ha hey had s opped
smoking cannabis in ecen mon hs, which was u -
he con i med by he u ine d ug es , and no
8
Ruiz-Veguilla e al.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56